|

Depression Clinical Trials in Las Vegas, NV

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDPhase 3<1 mi
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
Study of ALTO-300 in MDDPhase 2<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPhase 3<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive DisorderPhase 2<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Engage for Late-Life Depression and Comorbid Executive DysfunctionN/A<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 2<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.